HIGHLIGHTS
- who: Deborah L. Burnett and collaborators from the University of Catania, Italy have published the paper: Editorial: Decoding checkpoint inhibitor-induced endocrinopathies, in the Journal: (JOURNAL)
SUMMARY
Immune checkpoint (ICP), cancer immunotherapies, irAE, autoimmune disease, endocrinopathies Editorial on the Research Topic Decoding checkpoint inhibitor-induced endocrinopathies Immune checkpoint inhibitors have redefined the treatment landscape for many patients with cancer. As highlighted by Barnabei et_al, Muir et_al and Chye et_al, there are many single nucleotide polymorphisms (SNPs) with shared risk for endocrine irAEs and primary autoimmunity. Wu et_al show a similar trend of PD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.